# MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus

> **NCT00237653** · PHASE3 · TERMINATED · sponsor: **University Hospital, Grenoble** · enrollment: 40 (estimated)

## Conditions studied

- Cytomegalovirus Infections
- Inflammatory Bowel Diseases

## Interventions

- **DRUG:** Valganciclovir

## Key facts

- **NCT ID:** NCT00237653
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-02
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** difficulty to include patients
- **Last updated:** 2009-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00237653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00237653, "MICI-CMV:Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00237653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*